This test is most useful if any of these apply to you.
A positive stool result can help investigate a suspected enterovirus illness, but it can also reflect an infection that has already passed without causing symptoms. Viral genetic material may remain in stool for weeks after recovery. That makes stool useful as a supporting specimen in some meningitis investigations and makes an isolated positive easy to overinterpret.
PCR detection of enterovirus has an established role in selected infection workups. Using the amount found in stool to grade illness, guide treatment, or predict future autoimmune disease remains unvalidated. Published detection rates from hospital studies do not establish the performance of this particular laboratory assay.
Enteroviruses are a group of viruses whose genetic material is RNA. They include coxsackieviruses, echoviruses, and polioviruses. Many multiply in the gut and spread through contact with infected stool or secretions. Different types cause different illnesses, and some, particularly EV-D68, mainly infect the respiratory tract.
This stool test uses qPCR to detect and copy viral genetic material. Because enteroviruses carry RNA, testing includes a step that converts RNA into DNA before copying it. The full method is called reverse-transcription quantitative PCR and is usually written RT-qPCR. Detection does not establish whether the virus is still infectious, when you acquired it, or whether it caused symptoms elsewhere in your body.
The listed reporting unit is CFU/g stool. CFU means colony-forming units and ordinarily describes organisms grown in culture. Viruses do not form those colonies, and qPCR measures genetic material. The laboratory needs to clarify what this unit represents and how the result is calibrated before the number can be interpreted as a viral quantity.
A qPCR result cannot be converted into a count of infectious viruses without separate validation. Results from different laboratories, specimen types, or methods are not directly interchangeable. Some other enterovirus PCR tests report only detected or not detected; those results provide no numerical level to trend.
Meningitis is inflammation of the lining around the brain and spinal cord. Enteroviruses are a common viral cause, and PCR on spinal fluid is the main test used to establish enteroviral meningitis. Stool PCR can provide supporting evidence when that test is negative, particularly with later sampling. A positive stool result alone cannot establish infection of the brain or its lining, or exclude another cause.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Children with suspected enterovirus infection | RT-qPCR on stool, swabs from the back of the nose, blood, urine, and spinal fluid | Stool was positive in about 99% of children classified as enterovirus-positive by the study's methods. |
| Adults with confirmed enteroviral meningitis | PCR on stool, spinal fluid, and serum | Stool was positive in 24 of 25 samples. Spinal fluid detection was less frequent when collected later in the illness. |
| Children in North India with suspected central nervous system infection | PCR on rectal swabs or stool, throat swabs, and spinal fluid | Reported detection rates were about 90%, 32%, and 11%, respectively, in the study's selected analysis. |
These studies used different assays and definitions of infection. The North Indian study combined rectal swabs with stool and classified some infections using evidence outside spinal fluid; it also excluded children whose illness had no identified cause. Its figures should not be read as general performance estimates for diagnosing brain infection. In the adult study, stool remained positive in samples collected into the second week, but incidental stool positives also occurred in people with another established infection.
A separate hospital study found that a stool-only positive could be incidental, especially outside an enterovirus outbreak. That finding supports continued investigation when the symptoms and the stool result do not fit together.
Enteroviruses can cause hand, foot and mouth disease, painful throat blisters, and occasionally severe illness in newborns. EV-A71 can cause brainstem infection and sudden limb weakness. EV-D68 mainly causes respiratory illness and can cause acute flaccid myelitis. This condition affects the spinal cord and can suddenly weaken an arm or leg.
Stool is one of several specimens collected when sudden weakness is investigated, including to exclude poliovirus. Respiratory specimens are especially important for EV-D68, which stool testing can miss. A general enterovirus result does not identify the type unless the laboratory also performs type-specific testing or reads a distinguishing part of the viral genetic sequence.
In hospitalized children with hand, foot and mouth disease, higher EV-A71 genetic levels in throat swabs were associated with more neurological complications and intensive care admissions. That was a throat measurement for one viral type. It does not validate a stool quantity, including this test's CFU/g result, as a measure of how sick you are.
Some studies have followed children with inherited susceptibility to type 1 diabetes from birth. In Finland's DIPP study, researchers tested 4,781 stool samples from 129 children who developed multiple diabetes-related autoantibodies and 282 matched controls. These antibodies indicate an immune response directed against the pancreas's insulin-making cells.
During the period more than a year before those antibodies appeared, the children who later developed them had about three times the rate of stool-detected enterovirus infections. That difference was confined to that earlier period; it was not a threefold difference across the entire follow-up.
A 2023 review included 60 studies with about 12,000 participants. Its pooled analyses linked enterovirus detection to about twice the odds of diabetes-related autoantibodies and eight times the odds of diagnosed type 1 diabetes. Those analyses combined different detection methods and samples, including blood and pancreatic tissue. They do not mean that a positive stool result multiplies your child's future diabetes risk by eight.
Stool-specific findings have been mixed. A separate review of 38 studies found associations for blood and tissue, but no statistically clear association in its stool subgroup. Monthly stool testing in a Norwegian cohort also found no association with later diabetes-related autoantibodies. Another review used viral genetic sequencing, which differs from this qPCR method. It found about one and a half times the odds of consecutive enterovirus-positive stool samples in children with these antibodies.
The studies support investigating whether particular infections contribute to type 1 diabetes. They have not established a way to use a single stool result, or this test's numerical amount, to predict diabetes for you or your child. Differences in viral type, sampling frequency, specimen, and study design may help explain the conflicting findings.
Within a Norwegian cohort of 220 genetically susceptible children, researchers compared 25 who developed celiac disease with 50 matched controls. Enterovirus was detected more frequently in stool collected before celiac antibodies appeared, particularly after gluten had entered the diet. Infections lasting more than two months were associated with roughly twice the odds of later celiac disease. Adenovirus showed no such association.
This was an observational association from repeated childhood samples. It does not establish that enterovirus caused celiac disease or validate stool testing as an individual celiac-risk screen.
A positive stool result often gets blamed for diarrhea. In a Dutch case-control study, enterovirus was detected about as often in people without gastrointestinal symptoms as in those seeking care for them. The PCR signal strength did not reliably separate carriage from symptomatic illness.
A Thai study found enteroviruses in some people with otherwise unexplained gastroenteritis, but its comparison group had hand, foot and mouth disease without diarrhea. It was not a healthy control group, and the analysis included rhinoviruses. The study cannot establish that a positive stool enterovirus result explains your diarrhea. Other gut infections and noninfectious causes remain possible.
Passing viral material in stool can continue after symptoms stop. In a pilot study of five Australian infants, enterovirus was detected continuously for up to six weeks, usually without gastrointestinal symptoms. Longer episodes have been documented in other childhood studies, but duration varies and repeated positives can also represent separate infections.
A study of archived stool from three Brazilian children found enterovirus in about 64% of samples collected while they had no symptoms and 58% collected during illness. Those figures describe this very small historical sample, not the expected prevalence in your community. A separate Ghanaian study also detected enteroviruses in adults with and without HIV, without an association with gastrointestinal symptoms.
Some PCR reports include a Ct value. This counts the copying rounds needed for a detectable signal. Within the same assay, a higher Ct generally means less starting viral RNA, but it is also affected by sample quality and interference. It cannot reliably date an infection, establish contagiousness, or prove that a weak positive is harmless.
Enterovirus is best interpreted alongside these tests.
An at-home stool and urine test integrating microbiome balance, pathogens, digestion, permeability, immune activity, gut metabolites, and neurotransmitter patterns to clarify what is driving bloating, food reactions, fatigue, brain fog, and mood shifts.